Benjamin Halladay - Insider Trading & Ownership

Location
Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Summary
The estimated net worth of Benjamin Halladay is at least $1.68M dollars as of September 18, 2025. Benjamin Halladay is the Chief Financial Officer of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $1.68M.
Signature
/s/ Sheldon L. Koenig, by power of attorney
All Insider Reports
All Insider Reports

Ownership of Benjamin Halladay

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ESPR Esperion Therapeutics, Inc. Chief Financial Officer $1.68M -$41.3K -2.4% Sep 17, 2025

Insider Transactions Reported by Benjamin Halladay:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.